SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Clinical trial NCT07274774 · RECRUITING

Trial details

NCT number: NCT07274774
Sponsor: Shandong Cancer Hospital and Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma

Start date: 2025-11-30
Primary completion: 2027-11-10
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.